Strong Heart Study - The largest epidemiologic study of cardiovascular disease in American Indians

Approved Papers and Dissertations

Paper Proposals in Order of Year Approved

 

 

The following lists are in order from year 2018 in which the paper or dissertation/thesis proposals were approved. Click on the “year” to jump to the titles of approved paper proposals in that year.

Paper or dissertation/thesis proposals approval #s are in parentheses.

Paper Proposals in Order of Year Approved

[2023][2022][2021][2020][2019] [2018] [2017] [2016] [2015] [2014]

2023

  1. (799) Zhao J. Plasma lipidomic markers of left ventricular mass and left ventricular hypertrophy: A longitudinal study in American Indians in the Strong Heart Family Study.(Approved 2023-05-17)

  2. (798) Reese J. Vitamin D deficiency and cardiovascular disease risk factors in American Indian adolescents: The Strong Heart Family Study.(Approved 2023-05-17)

  3. (797) Navas-Acien A. Multi-cohort epigenome-wide association study of all-cause cancer and cardiovascular disease incidence.(Approved 2023-05-17)

  4. (796) Lieberman-Cribbin W. The association of blood lead and cadmium with cardiovascular disease incidence and mortality in the Strong Heart Study.(Approved 2023-05-17)

  5. (795) Harville E. Relationships between pregnancy complications and pre- and post-pregnancy cardiovascular health.(Approved 2023-05-17)

  6. (794) Eisele M. The burden of depressive symptoms in a cohort of American Indians after the COVID-19 outbreak: The Strong Heart Study.(Approved 2023-05-17)

  7. (793) Suchy-Dicey A. Adjudication of prevalent MCI and dementia in American Indians: data from the Strong Heart Study.(Approved 2023-04-17)
  8. (792) Kent B. The Study on Stress, Spirituality, and Health (SSSH): How Common are Beliefs in a Personal God across Four Racial/Ethnic Cohorts in the United States.(Approved 2023-04-17)
  9. (791) Kain K. Ankle systolic blood pressures prospective association with incident diabetes: The Strong Heart Study.(Approved 2023-04-17)
  10. (790) Reese J. A Community Health Promotion Project: Honoring the Gift of Heart Health, Amazing Race for Heart Health, and The Strong Heart Study. (Approved 2023-03-30)
  11. (789) Pan S. Associations of Pedometer-Measured Ambulatory Activity with Incidence of Atherosclerotic Cardiovascular Diseases: Strong Heart Family Study. (Approved 2023-03-30)
  12. (788) Ogungbe B. Health Care Utilization Disruptions and Resilience During the COVID-19 Pandemic in the C4R Data. (Approved 2023-03-30)
  13. (787) Leidner J. Application of a Data Cleaning Framework Using SAS and Excel. (Approved 2023-03-30)
  14. (786) Dye C. Socioeconomic Status, Biological Aging, and Markers of Cardiometabolic Disease Risk in the Strong Heart Family Study.(Approved 2023-03-30)
  15. (785) Zhao J. Plasma lipidomic markers of diet pattern and coronary heart disease risk in American Indians: the Strong Heart Family Study.(Approved 2023-02-21)
  16. (784) Mettler R. APOE Variation Associated with Cardiovascular Disease Risk among American Indians– A Strong Heart Study.(Approved 2023-02-21)
  17. (783) Li C. Longitudinal association among smoking and HbA1c, fasting glucose, 2-h glucose and serum lipids among American Indians with diabetes: The Strong Heart Family study.(Approved 2023-02-21)
  18. (782) Li C. Longitudinal association among alcohol consumption and HbA1c, fasting glucose, 2-h glucose and serum lipids among American Indians with diabetes: The Strong Heart Family study.(Approved 2023-02-21)
  19. (781) Cordero C. The Association Between Increased Caregiving and Women’s Mental Health During the COVID-19 Pandemic in the Collaborative Cohort of Cohorts for COVID-19 Research (C4R) Study.(Approved 2023-02-21)
  20. (780) Cole S. Determinants of hepatic steatosis and fibrosis in American Indian participants of the Strong Heart Liver Study.(Approved 2023-02-21)
  21. (779) Burns J. Associations of Obesity and Serum Indicators of Metabolic Syndrome with Left Ventricular Function in Native American Adolescents: A Strong Heart Family Study.(Approved 2023-02-21)
  22. (778) Nelson L. Qualitative Results of the American Indian Chronic Disease Risk and Sleep Health (AI-CHERISH) Study with the Strong Heart Family Study (SHFS) Cohort (Approved 2023-01-27)
  23. (777) Mokiao R. Associations of Kidney Disease Risk Factors and Kidney Dysfunction Among American Indian Adolescents and Adults: Strong Heart Family Study.(Approved 2023-01-27)
  24. (776) Balte P. COVID-19 risk and resilience factors in a US general population-based cohort, 2020-2022 (Approved 2023-01-27)


2022

  1. (775) Li Z. Association of Blood Metals and Mortality in American Indian Populations: a Prospective Cohort Study. (Approved 2022-12-20)

  2. (774) Zhao J. Plasma lipidomic markers of obesity: A longitudinal study in American Indians in the Strong Heart Family Study.(Approved 2022-11-21)

  3. (773) Zhao J. Plasma lipidomic markers for all-cause, CVD and cancer mortality in American Indians: The Strong Heart Family Study.(Approved 2022-11-21)

  4. (772) Su Y. Structural Brain Aging in a Native Indian Population: Data from the Strong Heart Study.(Approved 2022-11-21)

  5. (771) Shields A. The Association between DNA Methylation using Epigenome-wide Association Studies (EWAS) Method and Religious/Spirituality among Strong Heart Study Participants using Data from the Study on Psychosocial Stress, Spirituality and Health.(Approved 2022-11-21)

  6. (770) Shah S. Peripheral arterial disease prevalence and interventions in the Strong Heart Study.(Approved 2022-11-21)

  7. (769) Mokiao R. Diet Quality and Kidney Outcomes in Adolescent and Adult American Indians: The Strong Heart Family Study.(Approved 2022-11-21)

  8. (768) Li M. Fine particulate matter exposure, diabetes, metabolic syndrome, and cardiovascular disease in the Strong Heart Study.(Approved 2022-11-21)

  9. (767) Leidner J. Linking the Strong Heart Study to Medicare Data with Application to SHS Definite MI.(Approved 2022-11-21)

  10. (766) Zhao J. Plasma lipidomic markers of hypertension: A longitudinal study in American Indians in the Strong Heart Family Study.(Approved 2022-10-28)  

  11. (765) Wang K. Deep learning enables inference of hepatic proton-density fat fraction from T1-weigthed in-phase and opposed-phase MRI.(Approved 2022-10-28)

  12. (764) Stavrakis S. Atrial Myopathy as a Predictor of Ischemic Stroke Independent of Atrial Fibrillation in Native Americans: Analysis of Strong Heart Study.(Approved 2022-10-28)

  13. (763) Spaur M. Association of water metal and metalloid exposures with diabetes observed in US adults: The Strong Heart Study.(Approved 2022-10-28)

  14. (762) Solomon T. Characterization of American Indian and Alaskan Native Populations in the All of Us Research Program: A Demonstration Project with Comparison to the Strong Heart Study.(Approved 2022-10-28)

  15. (761) Lieberman-Cribbin W. The association of uranium in drinking water and urinary levels of uranium in the Strong Heart Study.(Approved 2022-10-28)

  16. (760) Lieberman-Cribbin W. Association of urinary uranium exposure with cardiac geometry and left ventricular function in the Strong Heart Study.(Approved 2022-10-28)

  17. (759) Eckhardt C. Cigarette Smoking, EV-encapsulated microRNAs, and all-cause mortality: evidence from the Strong Heart Study.(Approved 2022-10-28)

  18. (758) Castro-Diehl C. Sleep Problems predicting risk of post-acute sequelae of SARS-CoV-2 infection PASC .(Approved 2022-10-28)
  19. (757) Purpura L. Major predictors of SARS-CoV-2 nucleocapsid (N) antibody titer in infected participants.(Approved 2022-09-23)
  20. (756) Oelsner E. Epidemiologic features of recovery from SARS-CoV-2 infection in a US general population-based cohort: The C4R Study. (Approved 2022-09-23)
  21. (755) Li C. Longitudinal association among smoking, alcohol consumption and HbA1c, fasting glucose, 2-h glucose, HOMA-IR and serum lipids among American Indians with diabetes: The Strong Heart Family study. (Approved 2022-09-23)
  22. (754) Eisele M. Evaluation of Honoring the Gift of Heart Health: The Strong Heart Study. (Approved 2022-09-23)
  23. (753) Montileaux-Mabutt L. Periodontal disease as a cardiovascular disease risk factor. (Approved 2022-08-11)
  24. (752) Suchy-Dicey A. Diabetes, Kidney Disease, and Structural Parametric Mapping of Brain MRI: Data from the Strong Heart Study.(Approved 2022-07-19)
  25. (751) Ohno-Machado L. A Privacy-Preserving Federated Analytics Platform for Exploration and Learning on Vertically-Partitioned, Protected Multivariate Data from the Strong Heart Study.(Approved 2022-07-19)
  26. (750) Martinez-Morata I. Heart Failure risk prediction in a population with a high burden of diabetes and hypertension, evidence from the Strong Heart Study.(Approved 2022-07-19)
  27. (749) Elliot H. Systematic identification of methylation quantitative loci across populations. (Approved 2022-07-19)
  28. (748) Suchy-Dicey A. Bilingual status, brain imaging, and cognitive resilience in American Indians: data from the Strong Heart Study. (Approved 2022-06-24)
  29. (747) Ross C. Prescribed Opioids and neurocognitive status among American Indian populations. (Approved 2022-06-24)
  30. (746) Ohno-Machado L. Feasibility of Transforming Cohort Data Collected over the Span of 30-years to the OMOP Common Data Model: the Strong Heart Study.(Approved 2022-06-24)
  31. (745) Ohno-Machado L. Fast generalizable privacy preserving multivariate analytics platform for exploratory feasibility studies on Protected Data (Strong Heart Study).(Approved 2022-06-24)
  32. (744) Mckleroy W. The effect of inhaled steroid use and clinical features of COPD on risk of COVID-19 hospitalization, severity of disease, and mortality.(Approved 2022-06-24)
  33. (743) Kim E. The effect of cognitive reserve on a rhythm and timing intervention in older American Indians.(Approved 2022-06-24)
  34. (742) Goode C. Comparing Methods for Survival Analysis of Clustered Family Data in the Strong Heart Study: A Brief Report.(Approved 2022-06-24)
  35. (741) Eckhardt C. Extracellular vesicle-encapsulated microRNAs and respiratory health in the Strong Heart Study.(Approved 2022-06-24) 
  36. (740) Chen X.Assessing the Use of GEE Methods for Analyzing Binary Outcomes in Family Studies: The Strong Heart Family Study.(Approved 2022-06-24)
  37. (739)Bloss C.Facilitating Tribal Data Access in the Strong Heart Study: Collaborative Design of the “Data into Heart Health Action Dashboard.(Approved 2022-06-24)
  38. (738) Cornelius T. Co-Trajectories of Body Mass and Smoking Prior to, and During, the COVID-19 Pandemic. (Approved on 2022-05-16)
  39. (737) Suchy-Dicey A. Psychological resilience and cognitive resilience in American Indians: data from the Strong Heart Study. (Approved on 2022-05-16)
  40. (736) Best L. Selenium: Brain MRI Measures and Cognitive Function: the Strong Heart Stroke Study . (Approved on 2022-05-16)
  41. (735) Best L. Genetic Risk Factors for Pre-eclampsia: The Strong Heart Study. (Approved on 2022-05-16)
  42. (734) Suchy-Dicey A Plasma ATN biomarkers (neurofilament light chain, amyloid beta, tau) and Alzheimer’s disease in American Indians: data from the Strong Heart Study. (Approved on 2022-04-29)
  43. (733) Sotoodehnia N Epigenome-wide association study of ECG traits: CHARGE Consortium. (Approved on 2022-04-29)
  44. (732) Franceschini N Genetics of cardiovascular biomarkers in American Indians: the Strong Heart Study. (Approved on 2022-04-29)
  45. (731) Franceschini N Genetics of anthropometric traits in American Indians: the Strong Heart Study. (Approved on 2022-04-29)
  46. (730) Brit K The Impact of Religious Coping on Mental and Physical Health Among Individuals with History of Perceived Stress: A Pooled Analysis of the Study on Psychosocial Stress, Spirituality, and Health. (Approved on 2022-04-29)
  47. (729) Birch J Randomized Clinical Trial of Interactive Metronome Therapy on Depressive Symptoms in American Indians with Vascular Brain Injury. (Approved on 2022-04-29)
  48. (728) Suchy-Dicey A  Reliability, validity, sex, age cohort differences in MOCA scores in American Indian adults . (Approved on 2022-03-28)
  49. (727) Suchy-Dicey A  Reliability, validity, sex, age cohort differences in CVLT-II SF scores in American Indian adults . (Approved on 2022-03-28)
  50. (726) Suchy-Dicey A  Reliability, validity, sex, age cohort differences in OWA fas scores in American Indian adults . (Approved on 2022-03-28)
  51. (725) Suchy-Dicey A  Reliability, validity, sex, age cohort differences in WAIS digit symbol scores in American Indian adults . (Approved on 2022-03-28)
  52. (724) Suchy-Dicey A  Reliability, validity, sex, age cohort differences in 3MSE scores in American Indian adult. (Approved on 2022-03-28)
  53. (723) Hirsch J. Spatial and neighborhood data in the Collaborative Cohort of Cohorts for COVID-19 Research (C4R). (Approved on 2022-03-28)
  54. (722) Fretts A. Circulating Sphingolipids and All-Cause Mortality: The Strong Heart Family Study.(Approved on 2022-03-28)
  55. (721) Fretts A. Ambulatory Activity and All-Cause Mortality in Young and Middle-Aged Adults: the Strong Heart Family Study. (Approved on 2022-03-28)
  56. (720) Crivelli J. Associations of social determinants of health, dietary patterns, and kidney stone disease prevalence (Strong Heart Study). (Approved on 2022-03-28)
  57. (719) Best L. C-Reactive Protein Associated with the Interaction of Environmental Metal Exposures and Genetic Variants. (Approved on 2022-03-28)
  58. (718) Blaha M. The relationship of cigarettes, cigars, pipes, and smokeless tobacco use with clinical and subclinical cardiovascular disease: the Cross Cohort Collaboration Tobacco Working Group. (Approved on 2022-02-16)
  59. (717) Franceschini N. Replication of genetic variants in American Indians for chronic kidney disease traits and risk factors identified in U.S. Hispanics from Central America country of origin. (Approved on 2022-02-03)
  60. (716) Tellez-Plaza M. Pooled-cohorts genome-wide association study of metals: The Metal-GWAS Initiative. (Approved on 2022-01-26)
  61. (715) Lieberman-Cribbin W. Selenium Status and DNA methylation in the Strong Heart Family Study. (Approved on 2022-01-26)
  62. (714) Leidner J. Weighting Methods for the Strong Heart Liver Study. (Approved on 2022-01-26)
  63. (713) Kim J. Factors associated with post-vaccination antibody response in SARS-CoV-2.(Approved on 2022-01-26)
  64. (712) Amiri S. Area-Level Disadvantage and Brain Volume: The Strong Heart Study. (Approved on 2022-01-26)

2021

  1. (711) Shen Y. Predicting Incident Coronary Heart Disease by Learning Latent Space Representation of Individual Blood DNA Methylation from Strong Heart Study. (Approved on 2021-11-29)
  2. (710) Plante T. Cardiovascular Health as quantified by the American Heart Association’s Life’s Simple 7 (LS7) metric and risk of Covid-19 hospitalization. (Approved on 2021-11-29)
  3. (709) Parvez M. The effect of metals and smoking on SARS-CoV-2 and immune function: community and hospital-based studies. (Approved on 2021-10-22)
  4. (708) Palta P. Harmonization of Neurocognitive and Brain Imaging Data in the Collaborative Cohort of Cohorts of COVID-19 Research (C4R) Study. (Approved on 2021-10-22)
  5. (707) Oelsner E. Associations of Pipe and Cigar Smoking with DNA methylation at the Aryl Hydrocarbon Receptor. (Approved on 2021-10-22)
  6. (706) Kupsco A. Metal Mixtures and DNA Methylation Measures of Biological Aging in American Indians. (Approved on 2021-10-22)
  7. (705) Geleris J. Classifying COVID-19 Hospitalizations and Deaths in the Collaborative Cohort of Cohorts for COVID-19 Research (C4R) Study. (Approved on 2021-10-22)
  8. (704) Fretts A. Circulating Sphingolipids and Incident Chronic Kidney Disease: the Strong Heart Family Study. (Approved on 2021-10-22)
  9. (703) Balte P. Public health burden of tobacco use in the COVID-19 pandemic in the C4R Study. (Approved on 2021-10-22)
  10. (702) Best L. Genome-Wide Association Study of COVID-19 Outcomes: The Strong Heart Study. (Approved on 2021-09-17)
  11. (701) Zhao J. Plasma lipidome signatures associated with prevalent diabetes and prediabetes in a large sample of American Indians: the strong heart family study. (Approved on 2021-09-17)
  12. (700) Rogers P. Developing a Charlson Comorbidity Index for the American Indian Community: The Strong Heart Study. (Approved on 2021-09-17)
  13. (699) Demmer R. Analysis of SARS-CoV-2 Antibody Responses in C4R Participants. (Approved on 2021-09-17)
  14. (698) Bozack A. DNA methylation and urinary arsenic metabolite proportions: An epigenome-wide association study among adults with low-to-moderate arsenic exposure.(Approved on 2021-09-17)
  15. (697) Mascarenhas-Fonseca L. Sleep and cognition in American Indians: data from the Strong Heart Study (Approved on 2021-08-20)
  16. (696) Eisele M. Lipidomic profiling and perceived stress in American Indians: The Strong Heart Family Study (Approved on 2021-08-20)
  17. (695) Bhatt S. Lung Function and Cardiovascular Disease: Attributable Risk  (Approved on 2021-08-20)
  18. (694) Eyituoyo H. Alcohol consumption and left ventricular systolic function among American Indians: Data from the Strong Heart Family Study (Approved on 2021-08-03)
  19. (693) Navas-Acien A. Assessment of Differential Uranium Exposure and its Association with Hypertension and Elevated Blood Pressure in American Indian Communities in the Strong Heart Family Study (Approved on 2021-07-20)
  20. (692) Navas-Acien A. An integrative analysis of clinical and epigenetic biomarkers of mortalityion of traditional AI/AN culture and education with the risk of ischemic stroke: A post-hoc analysis of the Strong Heart Study (Approved on 2021-07-20)
  21. (691) Heath T. & Havenon A. Native Americans and the association of traditional AI/AN culture and education with the risk of ischemic stroke: A post-hoc analysis of the Strong Heart Study (Approved on 2021-07-20)
  22. (690) Reese J. Dyslipidemia and the incidence of subclinical and clinical cardiovascular disease in adolescents and young adults: the strong heart family study (Approved on 2021-06-16)
  23. (689) Kuehn E. Physical and Cognitive Function and its Relationship with Health-Related Quality of Life Among American Indians: Cross-Sectional Analysis of  Data from the Strong Heart Study (Approved on 2021-06-16)
  24. (688) Chen  X.  Assessing the Use of GEE Methods for Analyzing Data from Family Studies: Strong Heart Study (Approved on 2021-06-16)
  25. (687) Sawyer L. The impact of social support on diet quality and glycemic control among participants with type 2 diabetes: Insights from the Strong Heart Family Study
    (Approved on 2021-05-13)
  26. (686) Ravalli F. Critical Limb Ischemia Due to Toxic Metal Exposure in the Strong Heart Study(Approved on 2021-05-13)
  27. (685) OLeary M. Pioneers of Community Based Participatory Research:  The Strong Heart Study Community Engagement Model(Approved on 2021-05-13)
  28. (684) Navas-Acien A. Epiagenome-wide association study of blood lipid levels using the Illumina EPIC Chip: CHARGE Consortium(Approved on 2021-05-13)
  29. (683) Dye C. DNA Methylation Signatures of Maternal Arsenic Exposure Associated with Adult Offspring Diabetes in the Strong Heart Study and Strong Heart Family Study (Approved on 2021-05-13)
  30. (682) Diaz A. Assessment of Diagnostic Criteria of Early COPD: NHLBI Pooled Cohorts Study (Approved on 2021-05-13)
  31. (681) Best L. Genome-Wide Association Results for C-Reactive Protein: The Factors Influencing Pediatric Asthma Study. (Approved on 2021-05-13)
  32. (680) Best L. Genome-Wide Association Study of C-Reactive Protein: The Strong Heart Study (Approved on 2021-05-13)
  33. (679) Patterson K. Geographic and dietary differences of urinary uranium levels in the Strong Heart Family Study (Approved on 2021-04-16)
  34. (678) Montileaux Mabbutt  L. Tooth Loss in American Indian Populations and its Impact on Diet (Approved on 2021-04-16)
  35. (677) Claw K. Genome-wide association study of a nicotine metabolism biomarker in American Indian smokers from the Strong Heart Study (Approved on 2021-04-16)
  36. (676) Abuawad A. Arsenic Methylation, One-Carbon Metabolism, and Diabetes Incidence in the Strong Heart Family Study: An Untargeted Metabolomics Approach (Approved on 2021-04-16)
  37. (675) Navas-Acien A. Cardiovascular Disease Prevention in Women: Race/Ethnicity Implications (Approved on 2021-03-11)
  38. (674) Zhao J. Longitudinal metabolomic profiling of subclinical atherosclerosis in American Indians: The Strong Heart Family Study (Approved on 2021-03-11)
  39. (673) Zhao J. Longitudinal metabolomic profiling of depression in American Indians: The Strong Heart Family Study (Approved on 2021-03-11)
  40. (672) Zamora-Kapoor A. Body mass index trajectories and cognitive performance in American Indians: Evidence from the Cerebrovascular Disease and its Consequences in American Indians study (Approved on 2021-03-11)
  41. (671) Wu H. Asthma and obstructive sleep apnea in a sample of older American Indian Adults (Approved on 2021-03-11)
  42. (670) Nigra A. Decline in blood metals and subclinical cardiovascular outcomes: the Strong Heart Family Study (Approved on 2021-03-11)
  43. (669) Nigra A. Blood metal trends in the Strong Heart Family Study (Approved on 2021-03-11)
  44. (668) Domingo-Relloso A. Variable selection in the omics data setting: comparison of regularization methods using genome-wide DNA methylation data (Approved on 2021-03-11)
  45. (667) Cole S. Collaborative Cohort of Cohorts for COVID-19 Research (C4R) Study: Study Design (Approved on 2021-03-05)
  46. (666) Zhao J. Longitudinal metabolomic profiling of type 2 diabetes in American Indians: The Strong Heart Family Study(Approved on 2021-02-12)
  47. (665) Xu G. Association of selenium, zinc and other metal and metalloid exposures with cancer mortality in the Strong Heart Study (Approved on 2021-02-12)
  48. (664) Suchey-Dicey A. Longitudinal Cranial Magnetic Resonance Imaging and Change in Cognitive Function in American Indians: Data from the Strong Heart Study (Approved on 2021-02-12)
  49. (663) Pierce B.Association of common variation in the 10q24.32/AS3MT region with arsenic metabolism efficiency across three arsenic-exposed populations (Approved on 2021-02-12)
  50. (662 Addendum) Donahue R. Hyperinsulinemia/Insulin resistance and heart failure among American Indians. The Strong Heart Study (Approved on 2021-07-20)
  51. (662) Donahue R. Hyperinsulinemia/Insulin resistance and heart failure among American Indians. The Strong Heart Study (Approved on 2021-02-12)
  52. (630 Addendum) Chilton F. FADS-associated Phenotypes in Amerindian Populations: Strong Heart Study Original Cohort (Approved on 2021-01-05)

2020

  1. (661) Zamora-Kapoor A. Sex differences in obesity, vascular brain injury and cognitive performance in American Indians: Evidence from the Cerebrovascular Disease and its Consequences in American Indians (CDCAI) study (Approved on 2020-12-21)
  2. (660) Spaur M.  Association of metal and metalloid exposures in private wells and community water systems with urinary biomarkers observed in US adults: The Multi-Ethnic Study of Atherosclerosis and the Strong Heart Study (Approved on 2020-12-21)
  3. (659) Muller C.  Inverse Probability Weighting to Correct for Survivor Bias in the Strong Heart Stroke Study (Approved on 2020-12-21)
  4. (658) Fonseca L. Magnetic Resonance Imaging (MRI) findings associated with Intraindividual Cognitive Variability in Aging American Indians: insights on Alzheimer’s Disease and Related Dementia (ADRD)   (Approved on 2020-12-21)
  5. (657) Fabitz R. Longitudinal variation in hsCRP as a Risk Factor for Cardiovascular Disease and All-Cause Mortality: The Strong Heart Study (Approved on 2020-12-21)
  6. (656) Zhao J. Longitudinal lipidomics profiling of atherosclerosis in American Indians: The Strong Heart Family Study (Approved on 2020-11-13)
  7. (655) Yracheta J. AS3MT SNP & Haplotype Associations with Renal Function as Measured by Microalbuminuria, eGFR (Approved on 2020-11-13)
  8. (654) Rhoades D. Predictors of Ever Use of Electronic Cigarettes among American Indian Adults: the Strong Heart Study and Strong Heart Family Study (Approved on 2020-11-13)
  9. (653) Nigra A. Multivariate Bayesian Tobit imputation of urinary arsenic values below detection limits: Findings from NHANES and the Strong Heart Family Study (Approved on 2020-11-13)
  10. (652) Oord E. Replicating methylation-health outcome associations in the Strong Heart Study (Approved on 2020-10-15)
  11. (651) Suchey-Dicey A. Volume and Atrophy Estimation of Longitudinal Brain MRI in ADRD: Data from the Strong Heart Study (Approved on 2020-10-15)
  12. (650) Suchey-Dicey A. Machine learning clusters of findings from MRI: data from the Strong Heart Study (Approved on 2020-10-15)
  13. (649) Suchey-Dicey A. Case definition for mild cognitive impairment and dementia in American Indian elders: Data from the Strong Heart Study (Approved on 2020-10-15)
  14. (648) Rhoades D. Weight Satisfaction, Tobacco Use, and EC Use among American Indian Persons: the Strong Heart and Strong Heart Family Studies (Approved on 2020-10-15)
  15. (647) Rhoades D. Chronic Disease and Ever Use of Electronic Cigarettes Among American Indian Adults: the Strong Heart Study and Strong Heart Family Study (Approved on 2020-10-15)
  16. (646) Martinez Morata I. Associations between urinary metals and chronic heart failure in the Strong Heart Study (Approved on 2020-10-15)
  17. (645) Kent B. Dimensions of Religion and Spirituality Across Five Racial/Ethnic Communities in the United States: Results from the Study on Stress, Spirituality, and Health (Approved on 2020-10-15)
  18. (644) Bunch J. Self-reported history of head injury and the association with cerebrovascular disease and cognitive findings: analysis of the Strong Heart Study (Approved on 2020-10-15)
  19. (643) Wolf T.Association between Vitamin D and Type 2 Diabetes among Older American Indians(Approved on 2020-09-15)
  20. (642) Navas-Acien A. Arsenic Exposure, Blood DNA Methylation and Cardiovascular Disease in American Indian Adults (Approved on 2020-09-15)
  21. (641) Warner LN. Diet quality and depressive symptoms in a cohort of American Indians: The Strong Heart Family Study (Approved on 2020-8-10)
  22. (640) Navas-Acien A. Blood DNA Methylation and Liver Cancer: Evidence from Strong Heart Study (Approved on 2020-8-10)
  23. (639) Domingo-Relloso A. Smoking, blood DNA methylation profiles and incidence of smoking-related cancers in the Strong Heart Study (Approved on 2020-7-14)
  24. (638) Bloss C. Co-Design of a Community-Based Participatory Research Project Aimed at Investigating Tribal Perspectives on Privacy and Data Sharing:  A Workshop Report from the Strong Heart Study (Approved on 2020-7-14)
  25. (637) Reese J. Subclinical Vascular Abnormalities in Adolescents and Young Adults and the Risk of Fatal and Non-fatal Cardiovascular Events: The Strong Heart Family Study (Approved on 2020-6-16)
  26. (636) Franceschini N. Genetics of cardiovascular disease in American Indians: the Strong Heart Study (Approved on 2020-6-16)
  27. (635) Franceschini N. Genetics of blood pressure traits in American Indians: the Strong Heart Study (Approved on 2020-6-16)
  28. (634) Eagle Staff T. Depression, Physical Activity, and Incident Cardiovascular Diseases: The Strong Heart Family Study (Approved on 2020-6-16)
  29. (633) Ali T. Carotid Artery Atherosclerosis, MRI-defined Cerebral Vascular Injury and Atrophy, and Cognitive Performance in Elderly American Indians: The Strong Heart Study (Approved on 2020-6-16)
  30. (632) Best L. The ACE indel (I/D) polymorphism in relation to diabetic nephropathy, and hypertension: The Strong Heart Study. (Approved on 2020-5-15)
  31. (631) Zhou X. Evaluating the Influence of Religion and Spirituality on Diverse Health Outcomes Using Machine Learning Techniques. (Approved on 2020-5-14)
  32. (630) Chilton F. FADS-associated Phenotypes in Amerindian Populations: Strong Heart Study Original Cohort. (Approved on 2020-5-14)
  33. (629) Zhao J. Longitudinal Lipidomics Profiling of Hypertension in American Indians: The Strong Heart Family Study. (Approved on 2020-4-20)
  34. (628) Zhao J. Lipidomics Profile of arterial stiffness in American Indians: The Strong Heart Family Study. (Approved on 2020-4-20)
  35. (627) Spence N. Social Support and Leukocyte Telomere Length Among Participants in Four Prospective Cohort Studies: Nurses’ Health Study II, Black Women’s Health Study, Strong Heart Study, and Mediators of Atherosclerosis in South Asians Living in America Study. (Approved on 2020-4-20)
  36. (626) Grau-Perez M. Genetic determinants of renal function change among American Indians in the Strong Heart Family Study. (Approved on 2020-4-20)
  37. (625) Grau-Perez M. Epigenome-wide association study of prospective renal endpoints in the Strong Heart Study. (Approved on 2020-4-20)
  38. (624) Franceschini N. Genetics of kidney disease traits in American Indians: the Strong Heart Study. (Approved on 2020-4-20)
  39. (623) Cole S. Genetics of glucose dysregulation in American Indians: the Strong Heart Study. (Approved on 2020-4-20)
  40. (622) Belsky D. Pace of Aging analysis of healthspan and lifespan: Prospective analysis of associations of DunedinPoAm DNA methylation measure with incident chronic disease, disability, and mortality in the NHLBI Pooled Cohorts. (Approved on 2020-4-20)
  41. (621) Abuawad A. Arsenic Exposure, Epigenetic Aging and Incident Cardiovascular Disease in the Strong Heart Study. (Approved on 2020-4-20
  42. (620) Zhao J. Longitudinal lipidomics profiling of depression risk in American Indians: The Strong Heart Family Study. (Approved on 2020-3-17)
  43. (619) Shields A. Associations Between Psychosocial Stress and HPA Axis Gene DNA Methylation and the Modifying Role of Religion and Spirituality: A Pooled Analysis of the Study on Psychosocial Stress, Spirituality, and Health. (Approved on 2020-3-17)
  44. (618) Sanchez T. Metal-mixtures and chronic lung disease in the Strong Heart Study. (Approved on 2020-3-17)
  45. (617) Li Z. Blood Metal Levels in American Indian Populations, the Strong Heart Study (SHS). (Approved on 2020-3-17)
  46. (616) Argentieri A. The Impact of Religion and Spirituality on Patterns of HPA Axis Gene DNA Methylation: A Pooled Analysis of the Study on Psychosocial Stress, Spirituality, and Health. (Approved on 2020-3-17)
  47. (615) Zhao J. Longitudinal lipidomics profiling of CKD in American Indians: The Strong Heart Family Study. (Approved on 2020-2-14)
  48. (614) Goode C. Leukocyte Telomere Length and Stroke Risk in the Strong Heart Family Study. (Approved on 2020-2-14)
  49. (613) Brooks J. Long-Term Exposure to Ambient Air Pollution and Its Association with Hypertension in American Indians: The Strong Heart Study. (Approved on 2020-1-17)
  50. (612) Zhao J. Lipidomics Profile of Biological Aging in American Indians: The Strong Heart Family Study. (Approved on 2020-1-17)
  51. (611) Warner E. The Study on Stress, Spirituality, and Health (SSSH): Psychometric Evaluation and Initial Validation of the SSSH Baseline Spirituality Survey. (Approved on 2020-1-17)
  52. (610) Balte P. Comparing lung cancer risk prediction among men and women: The NHLBI Pooled Cohorts Study. (Approved on 2020-1-17)

2019

  1. (609) Warner E. Physical and Sexual Abuse in Childhood and Adolescence and Leukocyte Telomere Length: A Pooled Analysis of the Study on Psychosocial Stress, Spirituality, and Health. (Approved on 2019-12-19)
  2. (608) Zhao J. Genetic Variants, lipidomics and CVD in American Indians: Strong Heart Family Study. (Approved on 2019-12-12)
  3. (607) Bell J. Novel DNA methylation signatures of tobacco smoking. (Approved on 2019-12-12)
  4. (606) Tellez-Plaza M, Gonzalez J.  Prospective association of extreme down-regulation of chromosome Y and mortality in men from the Strong Heart Study. (Approved on 2019-11-12)
  5. (605) De Simone G. Myocardial Energetic Efficiency predicts composite CVD events in the Strong Heart Study population independently of structural CV damage. (Approved on 2019-11-12)
  6. (604) Balte P. Associations between metabolic syndrome and incident COPD: The NHLBI Pooled Cohorts Study. (Approved on 2019-11-12)
  7. (603) Baccarelli A. Blood DNA methylation biomarkers of cumulative lead exposure and incidence and mortality of cardiovascular disease in Strong Heart Study. (Approved on 2019-10-18)
  8. (602) Krishnan S. Improving atherosclerotic cardiovascular disease risk prediction in people with chronic obstructive pulmonary disease: NHLBI pooled cohorts study. (Approved on 2019-10-02)
  9. (601) Zhang Y. Elevation of Alanine and Aspartate Aminotransferase and Cardiovascular Diseases in a High-Risk Population: The Strong Heart Family Study. (Approved on 2019-8-22)
  10. (600) Fabsitz R. Visit to Visit Blood Pressure Variability as a Risk Factor for All-Cause Mortality, Cardiovascular Mortality, Incident MI and Incident Stroke Among American Indians: The Strong Heart Study. (Approved on 2019-8-22)
  11. (599) Jinying Z. Longitudinal lipidomics profiling of CVD risk in American Indians. (Approved on 2019-8-22)
  12. (598) Navas-Acien A. Meta-analysis of Genome-wide DNA Methylation and Fibrinogen Levels: Charge Consortium. (Approved on 2019-8-22)
  13. (597) Navas-Acien A. Epigenome-wide association study of kidney function-related traits: Charge Consortium. (Approved on 2019-8-22) 
  14. (596) Mayer M. Machine Learning Approaches for Environmental Mixtures Studies with Time to Event Outcomes and their Application to the Strong Heart Study. (Approved on 2019-8-22)
  15. (595) Zhao J. Longitudinal lipidomics profiling of diabetes risk in American Indians. (Approved on 2019-7-24)
  16. (594) Franceschini N. Phenome-wide association of functional coding variants and cardiometabolic phenotypes in American Indians. (Approved on 2019-7-24)
  17. (593) Crocker K. DNA methylation age and cultural connection among adults in the Strong Heart Study.  (Approved on 2019-7-24)
  18. (592) Carty C. Physical Activity and Cognitive Outcomes in the Strong Heart Study. (Approved on 2019-7-24)
  19. (589) Navas-Acien A.  DNA methylation signatures and incident cardiovascular disease in the Strong Heart Study.   (Approved on 2019-5-5)
  20. (588) Kent B. Religion, Spirituality, Ethnicity, and Health: Initial Findings from the National Consortium on Psychosocial Stress, Spirituality, and Health in Five Racial/Ethnic Groups. (Approved on 2019-5-5)
  21. (587) Shea S. Age-Period-Cohort (APC) Effects on Atherosclerotic Cardiovascular Disease Risk: the NHLBI Pooled Cohorts Study. (Approved on 2019-5-4)
  22. (586) Thuraisingam R. Lifestyle Factors and Cancer Risk among American Indian/Alaskan Natives: A Combined Women’s Health Initiative and Strong Heart Study Analysis. (Approved on 2019-5-4)
  23. (584) Zhao J. Genome-wide Association Study of Telomere Length: The Strong Heart Family Study.  (Approved on 2019-2-23)
  24. (583) Anderson M. Validating the National Stroke Association Stroke Risk Scorecard in American Indians: the Strong Heart Study. (Approved on 2019-2-23)
  25. (582) Olmedo B. IHS: From Framingham to the Strong Heart Study – Understanding Cardiovascular Disease and its Risk Factors among American Indian Men and Women. (Approved on 2019-1-30)
  26. (574) Oluwaseyi I. Cross-sectional and longitudinal associations between depression, childhood abuse, religious/spiritual identity, and telomere length in the Black Women Health Study, MASALA, Nurses’ Health Study II, and Strong Heart Study. (Approved on 2019-1-30)

2018

  1. (581) The WHO CVD Risk Chart Working Group Academic Coordinating Centre. Updating the World Health Organization (WHO) cardiovascular disease risk charts: Prediction algorithms to estimate risk in 21 global regions. (Approved on 2018-12-22)
  2. (580) Barbosa-Leiker C. Sex Differences in the Relationship between Psychological Health and Cognitive Impairment in American Indian Adults in the Cerebrovascular Disease and Its Consequences in American Indians (CDCAI) Study. (Approved on 2018-12-22)
  3. (579) Gribble M. Highly Adaptive Lasso (HAL) as a tool for studying environmental mixtures and health. (Approved on 2018-12-21)
  4. (578) Sanders J.  The association of leukocyte telomere length to longitudinal change in lung function and respiratory infection: Strong Heart and the NHLBI Pooled Cohorts Study. (Approved on 2018-12-21)
  5. (577) Zhao D, Navas-Acien A. The association of selenium and other metal/metalloids with incident cardiovascular disease in the Strong Heart Study. (Approved on 2018-12-03)
  6. (576) Lemaitre R. Plasma epoxyeicosatrienoic acids (EETs) and diabetes: the Strong Heart Study.  (Approved on 2018-12-03)
  7. (575) Kent B.  Religion and Spirituality in the National Consortium on Psychosocial Stress, Spirituality, and Health: South Asian, American Indian, Black, and White Women in the MASALA, Strong Heart, Black Womens’, and Nurses’ Health Studies.  (Approved on 2018-12-22)
  8. (573) Best L. Dietary Magnesium, C-reactive protein and Interluekin-6: The Strong Heart Study.  (Approved on 2018-10-18)
  9. (572) Tinkelman N, Navas-Acien A. Association of Parental Arsenic Exposure with Offspring Glucose and Insulin Resistance in the Strong Heart Study and Strong Heart Family Study. (Approved on 2018-10-18)
  10. (571) Wan E. Prevalence and risk patterns associated with Preserved Ratio Impaired Spirometry (PRISm): Strong Heart and the NHLBI Pooled Cohorts Study. (Approved on 2018-10-18)
  11. (570) Bhatt S. Derivation of a COPD Risk Score. (Approved on 2018-9-14)
  12. (569) Putcha N. Prevalence, risk factors, and longitudinal outcomes associated with asthma COPD overlap (ACO) in the NHLBI Pooled Cohorts study. (Approved on 2018-9-14)
  13. (568) Sanchez T. Arsenic exposure, epigenetics and lung disease in the Strong Heart Study. (Approved on 2018-9-13)
  14. (567) Sanchez T. DNA methylation profiles and lung disease in the Strong Heart Study. (Approved on 2018-9-13)
  15. (566) Sanchez T. Long-term respiratory effects of cigar and pipe use in the NHLBI Pooled Cohorts Study. (Approved on 2018-9-13)
  16. (565) Zhao J. Epigenome-wide association study of telomere length: The Strong Heart Study. (Approved on 2018-9-13)
  17. (564) Sanchez T. Long-term respiratory effects of secondhand smoke exposure among non-smokers in the NHLBI Pooled Cohorts Study. (Approved on 2018-08-31)
  18. (563) Hou R, Tellez-Plaza M. A gene by environment interaction analysis of cadmium exposure and MT polymorphisms with subclinical atherosclerosis and cardiac geometry and function in American Indians: The Strong Heart Family Study. (Approved on 2018-08-31)
  19. (562) Fawzey A, Umans J, Oelsner E. Aspirin use, lung function decline, and risk of COPD hospitalization and mortality: the NHLBI Pooled Cohorts Study. (Approved on 2018-08-30)
  20. (561) Crocker K, Navas-Acien A. DNA methylation and obesity phenotypes: an epigenome-wide association study among adults in the Strong Heart Study. (Approved on 2018-08-01)
  21. (560) Life expectancy associated with different ages at diagnosis of diabetes mellitus in 1.3 million adults. (Approved on 2018-06-24)
  22. (559) Powers M, Navas-Acien A. Pulmonary impairment after history of tuberculosis in American Indians in the Strong Heart Study.  (Approved on 2018-06-20)
  23. (558) Sanchez T, Uppal K. Metals and Novel Metabolism Biomarkers: Metallome Research in the Strong Heart Family Study. (Approved on 2018-06-20)
  24. (557) Riffo-Campos A,  Tellez-Plaza M. Epigenome-wide association study of cardiovascular and cancer mortality in the Strong Heart Study: An in silico analysis of common epigenetic signatures. (Approved on 2018-05-27)
  25. (556) Suchy-Dicey A. Resilience-promoting psychosocial and cultural factors in association with clinical outcomes among elderly American Indians: the Strong Heart Study. (Approved on 2018-05-27)
  26. (555) Everson T, Gribble M. Epigenetics of diabetes and diabetes-related traits in the Strong Heart Study.  (Approved on 2018-05-26)
  27. (554) Lee J. Endogenous Sex Hormones and Risk of Serious Diabetes Outcomes in Men with Diabetes: The Strong Heart Study. (Approved on 2018-05-25)
  28. (553) Lee J. Endogenous Sex Hormones and Cardio-metabolic Profiles in Men with Diabetes: The Strong Heart Study. (Approved on 2018-05-25)
  29. (552) Kummer K, Fretts A.  Dairy Consumption and Incident Diabetes Among American Indians: The Strong Heart Family Study. (Approved on 2018-05-01)
  30. (551) Eckhardt C. Associations between longitudinal lung function and the incidence of heart failure in the general population: The NHLBI Pooled Cohorts Study (including the Strong Heart Study). (Approved on 2018-05-08)
  31. (550) Domingo-Relloso A, Tellez-Plaza M. Navas-Acien A. Cadmium exposure, smoking and DNA methylation profiles in human blood DNA samples from the Strong Heart Study. (Approved on 2018-05-01)
  32. (549) Mancusi C. Myocardial Mechano-Energetic Efficiency and Insulin Resistance.  (Approved on 2018-05-01)
  33.  (548) Ritchey M. National Rates of Cardiovascular Disease Using Pooled Population Cohorts. (Approved on 2018-06-25)
  34. (547) Bozack A, Navas-Acien A. Loci-specific differential DNA methylation and urinary arsenic metabolites: An epigenome-wide association study among adults with low-to-moderate arsenic exposure. (Approved on 2018-03-31)
  35.  (545) Kauffman S, Fretts A. Interaction of Diet Quality and Blood Serum Lipid Levels in a Population at High Risk for Diabetes: The Strong Heart Family Study. (Approved on 2018-03-02)
  36. (544) Zhao J. Aspirin use, telomere length and cardiovascular disease among American Indians in The Strong Heart Family Study. (Approved on 2018-01-13)
  37. (543) Lemaitre RN. Circulating sphingolipids and incident cardiovascular disease in diabetes: the Strong Heart Study. (Approved on 2018-01-13)

2017

  1. (542) Zhao J. Telomere length and cancer mortality in American Indians: The Strong Heart Study. (Approved on 2017-12-29)
  2. (541) Tellez-Plaza M. Genetic determinants of unmodified cytosine content in human whole blood DNA: A Heritability and Quantitative Trait Locus Linkage Study in the Strong Heart Study. (Approved on 2017-11-18)
  3. (540) Spratlen MJ, Navas-Acien A.  Arsenic, one-carbon metabolism and Metabolic Syndrome in the Strong Heart Family Study. (Approved on 2017-11-18)
  4. (539) Pierce B. Sequencing-based fine-mapping of 10lq24.32/AS3MT and arsenic metabolism efficiency across three arsenic-exposed populations - Strong Heart Family Study. (Approved on 2017-11-16)
  5. (538) Balte PP. The prognostic significance of simple chronic bronchitis in the general population: the NHLBI Pooled Cohorts Study. (Approved on 2017-11-16)
  6. (537) Yi J, Navas-Acien A. Associations between metal exposure and sleep disorders in the Strong Heart Study. (Approved on 2017-11-15)
  7. (535) Zhao J. Integrated genetic and epigenetic analysis of the DNA methyltransferases family genes in relation to risk of diabetes in American Indians: the Strong Heart Study. (Approved on 2017-09-27)
  8. (534) Angelantonio ED. Comparing cardiovascular risk factors for venous and arterial thrombosis:  individual-participant data meta-analysis of 1.1 million participants in 76 prospective cohorts. (Approved on 2017-09-27)
  9. (532) Merkler AE. Unrecognized Myocardial Infarction and the Risk of Incident Ischemic Stroke in the Strong Heart Study. (Approved on 2017-08-18)
  10. (531) Losi MA. Depressed Myocardial Mechano-Energetic Efficiency is Associated with Increased Risk of Incident Heart Failure: The Strong Heart Study. (Approved on 2017-08-18)
  11. (530) Jones M. Metabolomics to Understand the Association between Arsenic Metabolism and Type 2 Diabetes: Preliminary Evidence from the Strong Heart Family Study. (Approved on 2017-09-27)
  12. (528) Fretts A, Lemaitre RN. Circulating sphingolipids and incident diabetes: the Strong Heart Study. (Approved on 2017-08-18)
  13. (527) Conner EL. The Role of Dietary Factors and Dietary Patterns on Circulating Sphingolipids: The Strong Heart Family Study. (Approved on 2017-06-10)
  14. (526) Miranda J. Association of arsenic exposure and metabolism biomarkers with diabetes-related traits. (Approved on 2017-06-10)
  15. (525) Suchy-Dicey A. Kidney function, cognitive impairment, and vascular brain injury in older American Indians. (Approved on 2017-05-10)
  16. (524) Pichler G, Navas-Acien A. The Association between Arsenic Exposure and Metabolism with Cardiac Geometry and Left Ventricular Function: Evidence from the Strong Heart Family Study. (Approved on 2017-05-09)
  17. (523) Haring B. Prognostic impact of changes in central blood pressure and left ventricular mass: Results from the Strong Heart Study. (Approved on 2017-04-08)
  18. (522) Zhao J. Telomere length and telomere attrition predict cardiovascular disease risk in American Indians: The Strong Heart Family Study. (Approved on 2017-04-08)
  19. (521) Lee J. Sex hormone levels and CVD risk in postmenopausal women with diabetes: The Strong Heart Study. (Approved on 2017-03-02)
  20. (520) Lee J. Sex hormone levels and CVD risk in men with diabetes: The Strong Heart Study. (Approved on 2017-03-02)
  21. (519) Nigra A, Navas-Acien A. Dietary sources of inorganic arsenic exposure in the Strong Heart Family Study. (Approved on 2017-02-28)
  22. (518) Almarzooq ZI. Associations of gender and diabetes mellitus with Physical Activity and Cardiovascular Mortality: The Strong Heart Study. (Approved on 2017-02-28)
  23. (517) Lewis JP. The contribution of binge drinking to hypertension, cerebrovascular disease, and stroke among older American Indians. (Approved on 2017-01-27)
  24. (516) Singh P. Physical Activity Decreases Cardiovascular Mortality via an Inflammatory Pathway:  The Strong Heart Study. (Approved on 2017-01-27)
  25. (515) Emerging Risk Factors Collaboration. Impact of re-calibrating cardiovascular risk prediction algorithms. (Approved on 2017-01-03)
  26. (514) Suchy-Dicey A. Kidney function patterns over time in the Strong Heart Study. (Approved on 2017-01-03)
  27. (511) Balakrishnan P. Cardiovascular Risk Factor Trajectories, Mortality, and Cardiovascular Disease Incidence among American Indians: The Strong Heart Study. (Approved on 2017-01-27)
  28. (507) Traore A. Impact of Stress on Fatal and Non-fatal Cardiovascular Disease among American Indians in Strong Heart Study. (Approved on 2017-05-09)
  29. (497, 536) Gribble MO, Arsenic, Blood Pressure and Hypertension in the Strong Heart Family Study. (Approved on 2015-12-08, 2017-9-28)

2016

  1. (513) Powers M, Navas-Acien A. Arsenic exposure and respiratory health in the Strong Heart Study. (Approved on 2016-11-18)
  2. (512) Oelsner EC. Harmonization of respiratory outcomes data from nine US population-based cohorts: the NHLBI Pooled Cohorts Study. (Approved on 2016-11-18)
  3. (510) Jones M, Navas-Acien A. Association between Arsenic Metabolism and Metabolic Syndrome: Evidence from the Strong Heart Family Study. (Approved on 2016-10-17)
  4. (509) Gribble MO. Arsenic Exposure, Arsenic Metabolism, and Trajectories of Diabetes-Related Traits in the Strong Heart Study. (Approved on 2016-10-17; Approved combining with #435 on July 30th, 2017)
  5. (508) Oelsner EC. Associations between Albuminuria and Incident Chronic Lower Respiratory Disease in Seven Population-Based Cohorts. (Approved on 2016-09-23)
  6. (506) Paige E. Modelling repeated measurements of blood pressure and cholesterol improves cardiovascular disease risk prediction: an individual-participant-data meta-analysis. (Approved on 2016-08-26)
  7. (505) Zamora-Kapoor A. Obesity and cognitive impairment in American Indians and Alaska Natives: Evidence from the Strong Heart Stroke Study. (Approved on 2016-07-18) (MS505 and MS533 were combined into a single manuscript (MS505). Approved by SHS P&P on 1/19/2018)
  8. (504) Zhao J. Plasma Plasminogen Activator Inhibitor-1 Antigen Predicts Risk of Incident Hypertension in American Indians: the Strong Heart Study. (Approved on 2016-05-26)
  9. (503) Zhao J. Association between Plasminogen Activator Inhibitor-1 and Biological Aging in American Indians: the Strong Heart Family Study. (Approved on 2016-04-12)
  10. (502) Nelson LA. An Urban Expansion of the Strong Heart Stroke Study: Preliminary Findings. (Approved on 2016-03-22)
  11. (501) Jensen P. Comparing Brain Imaging Findings Among American Indians in the Strong Heart Stroke Study to Whites and Blacks in the Cardiovascular Health Study and the Atherosclerosis Risk In Communities Study. (Approved on 2016-02-27)
  12. (500) Suchy-Dicey A. Metal exposure and MRI Findings of Atrophy and Vascular Brain Injury. (Approved on 2016-02-27)
  13. (499) Wang S, WITNESS: a Web InTerface to eNable secure sharEd-access to the Strong heart Study. (Approved on 2016-02-26)
  14. (498) Simone GD, Markers of preclinical CV disease and incident diabetes in the Strong Heart Study cohort. (Approved on 2016-02-26)

2015

  1. (497) Gribble MO, Arsenic, Blood Pressure and Hypertension in the Strong Heart Family Study. (Approved on 2015-12-08)
  2. (496) Zhao J. Associations between Leukocyte Telomere Length and Peripheral Artery Disease in American Indians: The Strong Heart Study. (Approved on 2015-12-08)
  3. (495) Aurora RN, Punjabi NM. Habitual Sleep Duration and Change in Sleep Duration as Predictors of All-Cause Mortality. (Approved on 2015-11-25)
  4. (494) Putcha N, Punjabi NM, Influence of Lung Function and Sleep-Disordered Breathing on All-Cause Mortality: A Community Based Study. (Approved on 2015-11-25)
  5. (493) Moon KA, Low-moderate Arsenic Exposure and Circulating Markers of Inflammation in the Strong Heart Family Study. (Approved on 2015-11-17)
  6. (492) Lemaitre RN, Circulating sphingolipids, fasting glucose and hemoglobin A1C: the Strong Heart Family Study. (Approved on 2015-11-17)
  7. (491) Chittoor G, Fine mapping and identification of serum uric acid loci in American Indians: The Strong Heart Family Study. (Approved on 2015-10-20)
  8. (490) Jones M, Navas-Acien A. Association between Arsenic Metabolism and One-Carbon Metabolism: Evidence from the Strong Heart Study. (Approved on 2015-09-16)
  9. (489) Verney ST. Cognitive Correlates of MRI-defined Vascular Brain Injury in the Strong Heart Stroke Study. (Approved on 2015-09-12)
  10. (488) Oliver-Williams C, Franceschini N. The association of Cadmium Burden and Longitudinal Blood Pressure: the Strong Heart Study. (Approved on 2015-08-24)
  11. (487) Powers M. Association of Urine Zinc with Prevalent and Incident Diabetes in the Strong Heart Study. (Approved on 2015-08-20)
  12. (486) Muller C. Age-period-cohort analysis of cardiovascular disease in American Indians: the Strong Heart Study and Strong Heart Family Study. (Approved on 2015-08-20)
  13. (485) Hardy ST. Transitioning from Ideal Blood Pressure Over the Life Course in Diverse Populations. (Approved on 2015-08-06)
  14. (484) Eilat-Adar S. The associations among coffee and caffeine intake and risk of coronary heart disease (CHD) or ischemic stroke in American Indians: The Strong Heart Study. (Approved on 2015-07-22)
  15. (483) Nigra A, Navas-Acien A. Associations between urinary tungsten and incident cardiovascular disease in the Strong Heart Study. (Approved on 2015-07-22)
  16. (482) Lemaitre RN. Acute Myocardial Infarction in American Indians:  STEMI vs. NSTEMI, Analysis of Strong Heart Study vs. Framingham Heart Study. (Approved on 2015-06-08)
  17. (481) Engeda JC. Net Transitions between Ideal, Intermediate, and Poor Levels of Total Cholesterol and Low Density Lipoproteins. (Approved on 2015-06-08)
  18. (480) Haring B. Processed and unprocessed meat intake, cardiac phenotype and vascular biomarkers:  Results from the Strong Heart Study. (Approved on 2015-05-14)
  19. (479) Shibata DK. Vascular risk factors and findings on brain MRI of elderly American Indians in the Strong Heart Stroke Study (paper 2). (Approved on 2015-05-14)
  20. (478) Grau-Perez M, Tellez-Plaza M. Association of arsenic and cadmium exposure with Leukocyte Telomere Length among American Indians in the Strong Heart Study. (Approved on 2015-04-09)
  21. (477) North K. Genetic Determinants of Anthropometric Traits in the Strong Heart Family Study. (Approved on 2015-04-09)
  22. (476) Angelantonio ED, Danesh J. N-terminal pro-B-type natriuretic peptide and prediction of cardiovascular disease. (Approved on 2015-04-09)
  23. (475) Hagerty T. Acute Myocardial Infarction in American Indians:  STEMI vs. NSTEMI, Analysis of Strong Heart Study vs. Framingham Heart Study. (Approved on 2015-04-01)
  24. (474) Moon KA. Low-moderate Arsenic Exposure and Electrocardiographic Abnormalities in the Strong Heart Study. (Approved on 2015-03-12)
  25. (473) Suchy-Dicey AM. Leukocyte telomere length and findings on cranial MRI: the Strong Heart Stroke Study. (Approved on 2015-03-12)
  26. (472) Shibata DK. Vascular risk factors and findings on brain MRI of elderly American Indians in the Strong Heart Stroke Study (paper 1). (Approved on 2015-05-14)
  27. (471) Grau-Perez M, Tellez-Plaza M. Genetic Determinants of Cadmium Exposure among American Indians in the Strong Heart Family Study. (Approved on 2015-02-10)
  28. (470) Danesh J, Angelantonio ED. Global and region-specific relationships of body-mass index and mortality: Collaborative analysis of 8.8 Million people in 233 prospective studies. (Approved on 2015-01-23)
  29. (469) Zhao J. Life’s simple 7 and telomere length in American Indians: The Strong Heart Family Study. (Approved on 2015-01-14)
  30. (468) Zhao J. Change-point proportional hazards model for clustered event data: an application to the Strong Heart Study. (Approved on 2015-01-15)
  31. (467) Zhao J. Telomere attrition and its impact on cardiac structural and functional changes in American Indians. (Approved on 2015-01-14)
  32. (466) Cholerton B, Calhoun D. Midlife insulin resistance and later cognitive function in older American Indians: The Strong Heart Stroke Study. (Approved on 2015-01-14)

2014

  1. (422) Tsai CW.  The association of five candidate genes and arsenic methylation in American Indians. (Approved on 2013-01-31)
  2. (423) Nicklett EJ.  Why does place matter? Examining differences in diabetes-related outcomes among Native American with type 2 diabetes by geographic density and distance to service. (Approved on 2013-01-31)
  3. (424) Gribble MO.  SLCO1B1 Variants and Urine Arsenic Metabolites in the Strong Heart Family Study. (Approved on 2013-01-31)
  4. (416) Zhao J. Metabolic profiles of biological aging in American Indians: The Strong Heart Family Study. (Approved on 2014-02-08)
  5. (417) Zhao J. Metabolic profiles and predictors for risk of type 2 diabetes in American Indians: The Strong Heart Family Study. (Approved on 2014-02-08)
  6. (425) Melton PE. Pharmacogenomics of glucuronidation in American Indians: The Strong Heart Family Study. (Approved on 2014-02-08)
  7. (426) Gribble MO. Arsenic Interactions with Genetic Determinants of Glycemia: Linkage and Association Analysis in the Strong Heart Family Study. (Approved on 2014-02-08)
  8. (427) Tsai CW. The association of PCSK9 polymorphism and metabolic traits in American Indians. (Approved on 2014-03-01)
  9. (428) Kuo CC. Arsenic metabolism and chronic kidney disease in the Strong Heart Study. (Approved on 2014-03-01)
  10. (429) Kuo CC. Arsenic exposure and metabolism and all-cause mortality in Strong Heart Study. (Approved on 2014-03-01)
  11. (430) Kuo CC. Arsenic Exposure and Incident Diabetes in the Strong Heart Study. (Approved on 2014-03-01)
  12. (431) Fretts AM. Meat Intake and Telomere Length: The Strong Heart Family Study. (Approved on 2014-03-01)
  13. (432) Fretts AM. Physical Activity and Telomere Length: The Strong Heart Family Study. (Approved on 2014-03-01)
  14. (436) Mateen FJ, Navas-Acien A. Urine arsenic exposure and Carotid Artery Vascular Disease: Prospective evidence from the Strong Heart Study. (Approved on 2014-03-29)
  15. (437) Deen JF. Sex Differences in QRS Duration and Associated Cardiovascular Events:  The Strong Heart Study. (Approved on 2014-05-08)
  16. (438) Marco MD. Sex difference in the cardiovascular risk associated with left ventricular hypertrophy:  The Strong Heart Study. (Approved on 2014-06-05)
  17. (439) Bang CN. Validation of a new 4-group Classification of Left Ventricular Hypertrophy Based on left Ventricular Geometry in a Population-Based Sample:  The Strong Heart Study. (Approved on 2014-06-05)
  18. (435) Kuo CC, Navas-Acien A. Arsenic Exposure and Incident Diabetes in the Strong Heart Family Study. (Approved on 2014-07-02; Approved combining with #509 on July 30th, 2017)
  19. (440) Carroll C. Latent Neuropsychological Effects of Chronic Low-Level Arsenic Exposure in American Indian Elders. (Approved on 2014-06-26)
  20. (441) Gribble MO. Genome-wide Linkage Analysis of Urine Arsenic Metabolites in the Strong Heart Family Study. (Approved on 2014-06-28)
  21. (442) Tsai CW. The association between obesity and kidney diseases in American Indians. (Approved on 2014-07-01)
  22. (443) Simone G. Hemodynamic correlates of aortic root dimensions in an adult population: the Strong Heart Study. (Approved on 2014-07-02)
  23. (444) Shara NM. Evaluation of the Pooled Cohort Equations for Cardiovascular Risk Prediction in a Population with high Prevalence of Obesity and Diabetes: The Strong Heart Study. (Approved on 2014-07-02)
  24. (445) Balakrishnan P, Navas-Acien A. Genetic Determinants of Incident Diabetes and Diabetes-Related Traits among American Indians in the Strong Heart Family Study. (Approved on 2014-07-15)
  25. (446) Gribble MO. Psychosocial Factors and Susceptibility to Arsenic for All-Cause Mortality in the Strong Heart Study. (Approved on 2014-07-16)
  26. (447) Newman JD. Inorganic arsenic exposure and incident peripheral arterial disease: the Strong Heart Study. (Approved on 2014-07-16)
  27. (448) Ton TGN. Brain imaging findings in Native Americans: The Strong Heart Stroke Study. (Approved on 2014-07-16)
  28. (449) Franceschini N. Association of coding variants in the CUBN gene with albuminuria in American Indians: The Strong Heart Family Study. (Approved on 2014-08-12)
  29. (450) Yeh F. The prevalence of Cardiovascular Disease Risk Factors in American Indian Communities: The Strong Heart Family Study. (Approved on 2014-08-13)
  30. (451) Muller C. Comparing stroke incidence and survival in American Indians, Blacks, and Whites: the Strong Heart Study, Atherosclerosis Risk in Communities Study, and the Cardiovascular Health Study. (Approved on 2014-08-13)
  31. (452) Wang W. Relationship of HbA1c and FPG and their performances in identifying new DM:   Strong Heart Study. (Approved on 2014-08-13)
  32. (454) Kaptoge S, Danesh J. Emerging Risk Factors Collaboration (ERFC): Diabetes duration and mortality. (Approved on 2014-08-18)
  33. (412) Shibata DK. Stroke and TIA Correlates of Brain MRI Abnormalities in the Strong Heart Stroke Study. (Approved on 2014-09-11)
  34. (455) Franceschini N, Cole SA. Genetic determinants of hypertension and kidney traits in American Indians: The Strong Heart Family Study. (Approved on 2014-09-11)
  35. (456) Balakrishnan P, Navas-Acien A. Genetic Determinants of Arsenic Exposure and Arsenic Metabolites among American Indians in the Strong Heart Family Study. (Approved on 2014-09-11)
  36. (457) Cole SA. Genome-wide association and trans-ethnic meta-analysis for advanced diabetic kidney disease: Family Investigation of Nephropathy and Diabetes (FIND). (Approved on 2014-09-24)
  37. (459) Traurig M, Baier LJ, Bogardus C. Interaction between SLC16A11 genotype and BMI conveys a nominal risk for type 2 diabetes in 13267 American Indians. (Approved on 2014-11-14)
  38. (460) Haring B. Left-ventricular Mass, MRI indices and Cognitive Functioning: Results from the Strong Heart Study. (Approved on 2014-11-14)
  39. (461) Zhao J. Novel metabolic markers for carotid plaque onset and progression in American Indians. (Approved on 2014-11-14)
  40. (462) Fretts AM. Artificial Sweeteners and Glucose Intolerance: the Strong Heart Family Study. (Approved on 2014-11-14)
  41. (463) Zhao J. Metabolic profiles of obesity in American Indians. (Approved on 2014-11-20)
  42. (464) Olmedo-Palma P,  Navas-Acien A. Dietary Determinants of Cadmium Exposure: Evidence from the Strong Heart Family Study. (Approved on 2014-12-10)
  43. (465) Dele-Michael A. Vascular structure and function as a predictor of left ventricular remodeling and hypertrophy:  The Strong Heart Study. (Approved on 2014-12-10)

Dissertation or Thesis Proposals Approved

  1. (T37) Kim J. Data Standardization, Federated Learning, and Informed Consent Algorithms and Tools to Honor Patient Privacy and Preferences in Clinical Research.(Approved 2023-05-19)
  2. (T36) Santorini S. Examining the Interplay of Social Connectedness, Depression, and Blood Pressure: The Strong Heart Family Study.(Approved 2023-03-30)
  3. (T35) Thomas N. Relationship between Indigenous women’s level of Allostatic Load and High Blood Pressure During Pregnancy; A Secondary Analysis of The Strong Heart Study.(Approved 2023-01-27)
  4. (T34) Paing P. Impact of Modified Life’s Essential 8 goals on incident cardiovascular diseases (CVD) in the Strong Heart Family Study.(Approved 2022-12-20)
  5. (T33) Goode C. Statistical Methods in Studying Age, Leukocyte Telomere Length, and Risk of Stroke in the Strong Heart Study.(Approved 2022-02-16)
  6. (T32) Eisele M. Statistical Methods in Analyzing the Association between Lipidomic Profiles and Perceived Stress: The Strong Heart Family Study.(Approved 2022-02-16)
  7. (T31) Slaney T. Within-subjects effects of an Interactive Metronome Treatment on Cognitive Functioning for Older American Indians with Cerebrovascular Disease (Approved 2021-12-21)
  8. (T30) Mokiao R. Associations of Diet Quality with Kidney Outcomes in Adolescents and Families: Strong Heart Family Study (Approved on 2021-01-05)
  9. (T29) Chen X, Zhao D. Assessing the use of GEE methods for analyzing continuous and binary outcomes and proposing a new Bayesian approach for analyzing survival outcomes for data obtained from family studies  (Approved on 2020-11-13)
  10. (T28) Warner LN, Fretts A. Assessing the association between diet quality and depressive symptoms in a cohort of American Indians: The Strong Heart Family Study. (Approved on 2020-01-17)
  11. (T27) Powers M, Navas-Acien A, Low-moderate Arsenic Exposure and Respiratory Health in American Indian Communities. (Approved on 2017-01-03)
  12. (T26) Conner EL, Lemaitre RN, The Role of Diet Quality and Dietary Factors on Circulating Sphingolipids: The Strong Heart Family Study. (Approved on 2016-11-18)
  13. (T25) Mattison C, Gribble M. Arsenic, Blood Pressure and Hypertension in the Strong Heart Family Study. (Approved on 2016-05-27)
  14. (T24) Kummer K, Fretts AM. Dairy consumption and incident type 2 diabetes among American Indians: the Strong Heart Family Study. (Approved on 2016-02-26)
  15. (T23) Moon K, Navas-Acien A. Subclinical and Clinical Cardiovascular Effects of Low-Moderate Arsenic: Evidence for Risk Assessment. (Approved on 2016-04-12)
  16. (T22) Kauffman SAE, Fretts AM. The Relationship of Diet Quality and Blood Serum Lipid Levels in a Population at High Risk for Diabetes: the Strong Heart Family Study. (Approved on 2015-08-24)
  17. (T21) Traore A, Eichner J. Impact of Stress on Fatal and Non-fatal Cardiovascular Disease among American Indians. (Approved on 2015-05-14)
  18. (T20) Kuo CC, Navas-Acien A. Arsenic exposure, metabolism and diabetes care in the Strong Heart Study. (Approved on 2014-06-30)
  19. (T19) Zheng L. Arsenic and Incident Chronic Kidney Disease in the Strong Heart Study. (Approved on 2014-02-08)